Endocrinology / diabetes clinical trials recruiting in Texas

505 recruiting endocrinology / diabetes trials match in Texas. Showing 20.

• IDOV-Immune for Advanced Solid TumorsRecruiting

  Phase 1 · ViroMissile, Inc. · Houston, Texas

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerRecruiting

  Phase 3 · Hoffmann-La Roche · Fort Worth, Texas

• Quantifying Hepatic Mitochondrial Fluxes in HumansRecruiting

  Phase 4 · The University of Texas Health Science Center at San Antonio · San Antonio, Texas

• Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older AdultsRecruiting

  N/A · Dartmouth-Hitchcock Medical Center · Manchester, New Hampshire

• Evaluating the Impact of a School-based Fruit and Vegetable Co-op on Cardiometabolic Child and Parents Health in a Persistent Poverty AreaRecruiting

  N/A · The University of Texas Health Science Center, Houston · Houston, Texas

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Dallas, Texas

• A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseRecruiting

  Phase 2 · Immunovant Sciences GmbH · Austin, Texas

• Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Recruiting

  Phase 2 · Sparrow Pharmaceuticals · Austin, Texas

• Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.Recruiting

  N/A · M.D. Anderson Cancer Center · Houston, Texas

• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusRecruiting

  Phase 3 · AstraZeneca · St Leonards

• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerRecruiting

  N/A · Natera, Inc. · Greenbrae, California

• Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)Recruiting

  Phase 1 · Radiomedix, Inc. · Houston, Texas

• Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Recruiting

  Phase 3 · NRG Oncology · Amarillo, Texas

• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruiting

  Phase 1 · IDEAYA Biosciences · Fort Worth, Texas

• NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM StudyRecruiting

  N/A · University of Texas Southwestern Medical Center · Dallas, Texas

• DFC 004 Biomarkers for Active Diabetic Foot UlcersRecruiting

  N/A · University of Michigan · San Antonio, Texas

• Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemRecruiting

  N/A · Insulet Corporation · Houston, Texas

• SPYRAL GEMINI Pilot StudyRecruiting

  N/A · Medtronic Vascular · Dallas, Texas

• Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruiting

  Phase 1 · Nammi Therapeutics Inc · San Antonio, Texas

• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesRecruiting

  Phase 3 · Sanofi · Houston, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.